Look for us at the 37th Annual J.P. Morgan Healthcare Conference taking place January 7-10, 2019 at the Westin St. Francis in San Francisco, CA.

Mission First-in-Class Pipeline

Scioto is developing innovative therapies devoted to having a significant impact on the delivery of microbiome therapeutics.

Our unique Activated Bacterial Therapeutic (ABT) platform leverages live therapeutic bacteria biofilms pre-colonized on microspheres allowing for enhanced function and persistent benefit.

Research and Development
First-in-Class Pipeline
Play Video